Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
暂无分享,去创建一个
G. Parmigiani | P. Futreal | P. Campbell | J. Teague | G. Bignell | K. Anderson | D. Wedge | S. Nik-Zainal | A. Butler | Jonathan Hinton | S. McLaren | L. Mudie | N. Bolli | P. Van Loo | I. Martincorena | J. Tubío | L. Alexandrov | N. Munshi | F. Iorio | P. Richardson | N. Rashid | K. Dawson | Elizabeth Anderson | Yilong Li | P. Moreau | A. Sperling | Y. Tai | M. Shammas | M. Fulciniti | F. Magrangeas | S. Minvielle | H. Avet-Loiseau | T. Facon | Sarah O' Meara | M. Attal | Sarah J O 'meara | K. Anderson | K. Anderson | Nikhil C. Munshi | Peter J. Campbell | Stuart McLaren | Adam P. Butler
[1] T. Chevassut,et al. The Genetic Architecture of Multiple Myeloma , 2014, Advances in hematology.
[2] Lisa J. Murray,et al. Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms , 2013, Leukemia.
[3] Steven A. Roberts,et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.
[4] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[5] David Beare,et al. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma , 2013, Nature Genetics.
[6] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[7] Carlos Caldas,et al. The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.
[8] N. Munshi,et al. Minor clone provides a reservoir for relapse in multiple myeloma , 2013, Leukemia.
[9] M. Stratton,et al. Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.
[10] A. McKenna,et al. Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia , 2012, Cell.
[11] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[12] J. Wolchok,et al. Progression of RAS-mutant leukemia during RAF inhibitor treatment. , 2012, The New England journal of medicine.
[13] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[14] M. Katoh,et al. Function and cancer genomics of FAT family genes , 2012, International journal of oncology.
[15] J. Carpten,et al. Clonal competition with alternating dominance in multiple myeloma. , 2012, Blood.
[16] A. Ashworth,et al. Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. , 2012, Blood.
[17] J. Carpten,et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. , 2012, Blood.
[18] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[19] A. Børresen-Dale,et al. The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.
[20] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[21] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[22] HaroldC. Smith,et al. Functions and regulation of the APOBEC family of proteins. , 2012, Seminars in cell & developmental biology.
[23] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[24] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[25] Eric S. Lander,et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing , 2012, Proceedings of the National Academy of Sciences.
[26] R. Bernards,et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR , 2012, Nature.
[27] Ryan D. Morin,et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. , 2012, Blood.
[28] M. Stratton,et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. , 2011, The New England journal of medicine.
[29] G. Morgan,et al. Mapping of Chromosome 1p Deletions in Myeloma Identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as Being Genes in Regions Associated with Adverse Survival , 2011, Clinical Cancer Research.
[30] D. Malide,et al. JTV1 co‐activates FBP to induce USP29 transcription and stabilize p53 in response to oxidative stress , 2011, The EMBO journal.
[31] C. Robert,et al. RAF inhibition and induction of cutaneous squamous cell carcinoma , 2011, Current opinion in oncology.
[32] Trevor J Pugh,et al. Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.
[33] K. Anderson,et al. Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.
[34] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[35] P. A. Futreal,et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.
[36] Andrew Menzies,et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.
[37] C. Perou,et al. Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.
[38] J. Keats,et al. Classical and/or alternative NF-kappaB pathway activation in multiple myeloma. , 2010, Blood.
[39] Richard Durbin,et al. Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..
[40] F. Zhan,et al. Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma. , 2010, Blood.
[41] J. Salk. Clonal evolution in cancer , 2010 .
[42] B. Barlogie,et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review , 2009, Leukemia.
[43] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[44] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[45] Jeong Do Kim,et al. Two evolutionarily conserved sequence elements for Peg3/Usp29 transcription , 2008, BMC Molecular Biology.
[46] Guy Pratt,et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia , 2008, Nature Genetics.
[47] L. Bruhn,et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. , 2007, Cancer cell.
[48] Kenneth C. Anderson,et al. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets , 2007, Nature Reviews Cancer.
[49] M. Stratton,et al. Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer , 2006, Genetics.
[50] P. L. Bergsagel,et al. Molecular pathogenesis and a consequent classification of multiple myeloma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] L. Pasqualucci,et al. Expression of the AID protein in normal and neoplastic B cells. , 2004, Blood.
[52] P. Green,et al. Bayesian Markov chain Monte Carlo sequence analysis reveals varying neutral substitution patterns in mammalian evolution. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[53] Jack E. Dixon,et al. Sorting out the cellular functions of sorting nexins , 2003, Nature Reviews Molecular Cell Biology.
[54] M. Marin,et al. Implication of the Lymphocyte-Specific Nuclear Body Protein Sp140 in an Innate Response to Human Immunodeficiency Virus Type 1 , 2002, Journal of Virology.
[55] P. Frey,et al. Concerted and stepwise dehydration mechanisms observed in wild-type and mutated Escherichia coli dTDP-glucose 4,6-dehydratase. , 2002, Biochemistry.
[56] P. L. Bergsagel,et al. Chromosome translocations in multiple myeloma , 2001, Oncogene.
[57] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[58] D. Sassoon,et al. Peg3/Pw1 is an imprinted gene involved in the TNF-NFκB signal transduction pathway , 1998, Nature Genetics.
[59] S. Hattori,et al. Purification of a novel ras GTPase-activating protein from rat brain. , 1993, The Journal of biological chemistry.
[60] Carl F. Ware,et al. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface , 1993, Cell.
[61] O. Cope,et al. Multiple myeloma. , 1948, The New England journal of medicine.